Answers are grounded in this paper and cite their sources.
Objectives Many individuals at high risk for renal disease remain undetected in clinical practice due to insufficient testing of estimated glomerular filtration rate (eGFR) and urine albumin‐to‐creatinine ratio (uACR). This study aims to develop models to predict reduced eGFR and elevated uACR, thereby facilitating early identification of individuals at risk. Methods From 72,346 analyzed samples, we derived a dataset containing 15 features (U15). We developed three evolutionary learning‐based models: PeGFR, PuACR1, and PuACR2, to predict eGFR < 60 mL/min/1.73 m 2 , uACR ≥ 30 mg/g, and uACR > 300 mg/g, respectively. These models were built using an intelligent bi‐objective combinatorial genetic algorithm (IBCGA) and SVM parameter settings optimized simultaneously. External dataset without eGFR and uACR measurements to evaluate clinical applicability. Results In the U15 training and test datasets for uACR prediction, gender, pH, and bilirubin were not statistically significant; whereas all features were significant in eGFR prediction ( p < 0.05). The areas under the curve (AUC) for PeGFR, PuACR1, and PuACR2 were 0.846, 0.827, and 0.949, respectively. In the external test, 589 individuals (11.36%) were identified as high‐ or very‐high‐risk, defined as having eGFR < 60 mL/min/1.73 m 2 and uACR ≥ 30 mg/g. Conclusions The evolutionary learning framework proposed accurately predicts renal risk using clinical data as an early screening tool. It also demonstrates scalability in assisting healthcare providers in determining whether further renal‐related examinations are warranted, thereby facilitating the identification of high‐risk individuals for secondary prevention. An online tool has also been developed for clinical and research use: https://nycuiclab.ngrok.io .
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: